Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $5.25 at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its price objective cut by Truist Financial from $6.00 to $5.25 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a hold rating on the stock.

Aveanna Healthcare Trading Down 3.2 %

AVAH opened at $4.51 on Monday. Aveanna Healthcare has a twelve month low of $2.00 and a twelve month high of $6.19. The firm has a market cap of $871.44 million, a price-to-earnings ratio of -13.26 and a beta of 2.25. The company has a fifty day simple moving average of $5.14 and a 200 day simple moving average of $4.71.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $509.02 million for the quarter, compared to analyst estimates of $495.80 million. During the same quarter in the prior year, the business earned ($0.05) earnings per share. On average, analysts forecast that Aveanna Healthcare will post -0.08 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its stake in Aveanna Healthcare by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after acquiring an additional 63,190 shares during the last quarter. State Street Corp grew its position in shares of Aveanna Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company’s stock worth $5,408,000 after acquiring an additional 9,446 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Aveanna Healthcare by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after purchasing an additional 17,522 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its stake in Aveanna Healthcare by 297.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock valued at $1,848,000 after purchasing an additional 265,969 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.